BioMark Provides Second Quarter Operational Update and Announces Extension to Warrant Exercise Term

Stock Information for BioMark Diagnostics Inc

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About BioMark Diagnostics Inc

BioMark Announces Warrant Extension and Granting of Options
BioMark to Advance Development of Cancer Treatment for Glioblastoma
BioMark Partners with Rubix LS to Advance Blood-Based Cancer Screening in Underserved Communities
Theresa Peterson Joins Biomark's Advisory Team
BioMark Announces Closing of $1.9 Million Non-Brokered Private Placement
BioMark Announces Recent New Patent Granted in Canada to Support Its Liquid Biopsy Based Legacy Assay
BioMark Strengthens and Expands Its Strategic Advisory Team in Pursuit of Commercialization Initiatives
BioMark Announces Financial Contribution from the City of Quebec to Support Commercialization Initiatives of Its Proprietary Lung Cancer Detection Test

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.